http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111518915-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d1be2e43b03651eaf931a8af98ff10d9 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2020-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acda8da83f91d5e6c48451d36b9941f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87c80ed10a0201e10aaaf66a6047fc36 |
| publicationDate | 2020-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111518915-A |
| titleOfInvention | Marker and kit for local prostate cancer clinical risk prediction |
| abstract | The invention relates to the field of biomedicine, in particular to a marker and a kit for local prostate cancer clinical risk prediction. The kit comprises primers and probes for quantifying mRNA corresponding to fcn1, il1b, lilrb3, mefv, ppt1, rassf2 and serpina1 genes of extracellular vesicles in a blood sample. The invention applies gene expression profile combination to risk grade grading of localized prostate cancer for the first time. The kit and the marker group for the diagnosis and grading of the localized prostate cancer are provided, so that the grading diagnosis of the prostate cancer can be better realized in a non-invasive way, and the sensitivity, specificity and accuracy of the diagnosis are improved. |
| priorityDate | 2020-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 30.